ACTRN12612000176864: A Randomized, Double-blind, Placebo-controlled, First-in-human, 3-Part Study of Orally Administered ALS-002158 to Evaluate the Safety, Tolerability and Pharmacokinetics of
Single Ascending Dosing and Food-effect in Healthy Volunteers, and Multiple Ascending Dosing in Subjects with Chronic Hepatitis C Genotype 1 Infection. |
|
|
| Recruiting | 1 | 78 | | | CPR Pharma Services, Alios BioPharma Inc | Chronic Hepatitis C infection | | | | |